Aspirin → alopecia areata — Null result

← All findings ⬇ Download signed audit packet

Ledger entry · null-result

Aspirin → alopecia areata — Null result

Drug: aspirin · AE: alopecia areata

Caliper validation of the submitted claim (drug=aspirin, AE=alopecia areata). BELOW_DEDUP_THRESHOLD — only 1 unique cases after dedup; insufficient signal density

Disproportionality

PRR: 0.4489951894978196 (95% CI 0.06–3.19)
Yates χ²: 0.23689154629494588
Cases (case-drug + AE): n = 1
Verdict: BELOW_DEDUP_THRESHOLD — only 1 unique cases after dedup; insufficient signal density

Top reactions in cohort

MedDRA PT	n
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.

Independent Verification & Validation

Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.

Reference: a94bc248d7387910d6afe2a7107541156ceea1e0